Arun Jesudian, MD
Hepatology · New York, NYNPI 1265699821
Payments from drug & device makers
Across 798 payments — averaging $1097.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$528K
- Mallinckrodt Hospital Products Inc.$137K
- Dynavax Technologies Corporation$74K
- Madrigal Pharmaceuticals$54K
- Bausch Health US, LLC$48K
- Novo Nordisk$13K
- plus $21K from 12 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 591 | $527,651 |
| Mallinckrodt Hospital Products Inc. | 86 | $136,919 |
| Dynavax Technologies Corporation | 10 | $74,272 |
| Madrigal Pharmaceuticals | 67 | $54,402 |
| Bausch Health US, LLC | 2 | $47,750 |
| Novo Nordisk | 5 | $13,484 |
| Gilead | 14 | $5,731 |
| Bard Peripheral Vascular, Inc. | 2 | $5,355 |
| Ipsen Biopharmaceuticals, Inc | 8 | $4,582 |
| Spectrum Pharmaceuticals Inc. | 1 | $2,620 |
| Grifols Therapeutics LLC | 1 | $2,050 |
| ZOLL Medical Corporation | 1 | $375 |
| Mirum Pharmaceuticals, Inc. | 4 | $188 |
| Grifols, S.A. | 1 | $118 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $118 |
| Intercept Pharmaceuticals, Inc. | 2 | $82 |
| Orphalan Inc | 1 | $19 |
| Stereotaxis Inc | 1 | $15 |
How this compares
$875,732 in reported general payments places this provider in the 85th percentile of 29 hepatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hepatology in New York
- Robert BrownNew York$2.1M
- Douglas DieterichNew York$1.1M
- Howard WormanNew York$962K
- Meena BansalNew York$868K
- Jennifer LeongNew York$379K
- Tatyana KushnerNew York$322K
- Albert MinNew York$284K
- Joseph OdinNew York$115K
- Russell RosenblattNew York$90K
- Thomas SchianoNew York$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.